Sugi Predict

Sugi Predict / Compounds / SCHEMBL204605

SCHEMBL204605

SCHEMBL204605

CS(=O)(=O)c1nc2cnc3cccnc3c2[nH]1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK2A1 P68400 1/20 0.39
▸ KDM4E B2RXH2 6/20 0.37
▸ ALDH1A1 P00352 2/20 0.36
▸ HTT P42858 2/20 0.36
▸ HPGD P15428 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ GLO1 Q04760 1/20 0.36
▸ MAPT P10636 4/20 0.35
▸ CBFB Q13951 1/20 0.35
▸ SLC40A1 Q9NP59 1/20 0.34
▸ MAPK1 P28482 2/20 0.33
▸ GAA P10253 2/20 0.33
▸ APOBEC3G Q9HC16 2/20 0.33
▸ CDK9 P50750 1/20 0.33
▸ DYRK1A Q13627 1/20 0.33
▸ DYRK1B Q9Y463 1/20 0.33
▸ SCD O00767 1/20 0.33
▸ PTGS1 P23219 1/20 0.33
▸ PTGS2 P35354 1/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL202971 0.79 ALDH1A1 (0.41) CSNK2A1KDM4EALDH1A1HPGDPTGS1
SCHEMBL4390168 0.78 CSNK2A1 (0.40) CSNK2A1KDM4EALDH1A1HTTHPGD
SCHEMBL311171 0.77 KDM4E (0.41) KDM4EALDH1A1HTTALOX15MAPT
SCHEMBL14643285 0.77 SMN1; SMN2 (0.39) KDM4EALDH1A1HTTALOX15GLO1
SCHEMBL1699171 0.75 ALDH1A1 (0.41) CSNK2A1ALDH1A1HTTHPGDALOX15
SCHEMBL311312 0.74 KDM4E (0.41) KDM4EALDH1A1HTTALOX15MAPT
SCHEMBL1490778 0.74 NUDT1 (0.42) KDM4EALDH1A1HTTALOX15MAPT
SCHEMBL2086309 0.74 KDM4E (0.39) KDM4EALDH1A1HTTALOX15MAPT
SCHEMBL202410 0.74 KDM4E (0.40) CSNK2A1KDM4EALDH1A1HTTHPGD
SCHEMBL14643308 0.71 CYP1A2 (0.39) KDM4EALDH1A1HTTALOX15MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8329721-B2 Hydroxy and alkoxy substituted 1H-imidazonaphthyridines and methods 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-12-11 — — US disclosed
US-8088788-B2 Substituted fused[1,2] imidazo[4,5-c] ring compounds and methods 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-01-03 — — US disclosed
US-20090298821-A1 HYDROXY AND ALKOXY SUBSTITUTED IH-IMIDAZONAPHTHYRIDINES AND METHODS PFIZER INC. 2009-12-03 — — US disclosed
US-20090221551-A1 SUBSTITUTED FUSED[1,2] IMIDAZO[4,5C] RING COMPOUNDS AND METHODS PFIZER INC. 2009-09-03 — — US disclosed
WO-2007106854-A2 HYDROXY AND ALKOXY SUBSTITUTED 1H-IMIDAZONAPHTHYRIDINES AND METHODS COLEY PHARMACEUTICAL GROUP, INC. (US) 2007-09-20 — — WO disclosed
WO-2007106852-A2 SUBSTITUTED FUSED[1,2]IMIDAZO[4,5-C] RING COMPOUNDS AND METHODS COLEY PHARMACEUTICAL GROUP, INC. (US) 2007-09-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298821-A1 HYDROXY AND ALKOXY SUBSTITUTED IH-IMIDAZONAPHTHYRIDINES AND METHODS IL2, IL4, IFNG CSNK2A1 1993/4885KDM4E 2756/4885ALDH1A1 787/4885
US-20090221551-A1 SUBSTITUTED FUSED[1,2] IMIDAZO[4,5C] RING COMPOUNDS AND METHODS IL2, IFNG, IL4 CSNK2A1 654/4885KDM4E 2419/4885ALDH1A1 979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.